University of pennsylvania: a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy and safety of daily oral low dose ulipristal acetate…
Ended Awarded Last action
- Contract number
- HHSN27500002
- Awardee
-
The Trustees Of The University Of Pennsylvania UEI GM1XX56LEP58
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,400,056
Award facts
- Contract value 100% obligated
- $1,400,056.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 20 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$256 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $200,402 | |
| Funding Only Action | $125,137 | |
| Funding Only Action | $165,260 | |
| Other Administrative Action | -$1,966 | |
| Funding Only Action | $15,133 | |
| Other Administrative Action | $0 | |
| Original award | $896,346 |
About this award
This is a federal contract award to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, by the National Institute of Child Health and Human Development (NICHD). The contract is a Delivery Order valued at $1,400,056.16 for a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy, and safety of daily oral low-dose ulipristal acetate. The contract is part of the Contraceptive Clinical Trials Network Female Sites program and has a period of performance through March 31, 2022. The contract does not have a set-aside designation. The University of Pennsylvania is a leading private research university and academic medical center with extensive expertise in biomedical research, clinical trials, and federal government contracting.
Description
University of pennsylvania: a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy and safety of daily oral low dose ulipristal acetate HHSN275201300020I/HHSN275200002
Quick answers
Who was awarded contract HHSN27500002?
HHSN27500002 was awarded to The Trustees Of The University Of Pennsylvania by National Institute of Child Health and Human Development (National Institutes of Health) on July 16, 2013.
How much is contract HHSN27500002 worth?
The government has obligated $1,400,056 on HHSN27500002.
Is contract HHSN27500002 an order under another contract?
Yes. HHSN27500002 is a delivery order under HHSN275201300020I, an indefinite delivery contract.
Was contract HHSN27500002 competed?
The extent of competition for HHSN27500002 was full and open competition. The government received 20 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award